Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Hyperbaric Oxygen Therapy to Help Fat Grafts Take in Irradiated Breast

Official title: Prospective Study to Evaluate the Effectiveness of Hyperbaric Oxygen Therapy (HBOT) to Increase the Survival of Autologous Fat Transfer for Breast Reconstruction After Radiotherapy: A Randomized Controlled Phase II Cross-over Trial

Run by University Hospital, Geneva · NCT07140198 · Data updated 2026-11-12

This trial tests whether breathing pure oxygen in a pressurized chamber helps fat grafts survive better in women who had breast radiation.

More Breast Reconstruction trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment16 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Drugs / interventionsradiation
Locations1 site (Geneva, Canton of Geneva)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedNovember 2028
Study endsDecember 2028
Registry record updatedMay 14, 2026
Trial IDNCT07140198 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women who have had breast radiotherapy and are scheduled for two lipofilling procedures as part of reconstruction.

Probably not a fit

Patients without radiotherapy or those not undergoing both grafting sessions may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, crossover, single-center study enrolling 16 adult women who will receive two autologous fat grafting sessions: one with hyperbaric oxygen therapy (HBOT) and one without. HBOT involves 90 minutes of 100% oxygen at 2.5 atmospheres absolute, given in five sessions after the fat grafting procedure. Each participant serves as her own control, with MRI assessments at six months after each graft to measure fat retention and safety outcomes monitored throughout. The trial aims to determine if HBOT improves graft survival and is tolerable in irradiated breast tissue following lipofilling.

Why it matters

Potential benefit: If successful, HBOT could improve fat graft retention and reduce complications in irradiated breast reconstruction.

How similar studies have gone: Previous data suggest HBOT can enhance tissue oxygenation and healing, but its effectiveness for fat graft retention in irradiated breast tissue is being tested in this crossover trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (18 y.o. or more) female patients considered for lipofilling following breast reconstruction in an oncological setting which received radiation therapy on the affected breast.
* Ability to provide informed consent, documented by signature

Exclusion Criteria:

* Pregnancy or breastfeeding
* Unability to provide informed consent
* Previous enrolment into the current investigation

Contra-indication to HBOT :

* Anamnestically reported spontaneous pneumothorax
* Status post-thoracotomy
* Significant intra-pulmonary lesions (including emphysematous bullae)
* Respiratory function disorders (both obstructive and restrictive syndromes)
* Pregnancy
* Major psychiatric disorders
* Uncontrollable claustrophobic reaction
* Seizures, even if treated and asymptomatic for some time
* Status post-severe traumatic brain injury with neurological deficits and seizures
* Decompensated heart failure
* Recent myocardial infarction (\<6 months) or with persistent hemodynamic sequelae
* Spastic coronary angina
* Cardiac arrhythmias, atrioventricular block, Wolff-Parkinson-White syndrome, sinus node dysfunction, Lown-Ganong-Levine syndrome
* Cardiac pacemakers with unknown pressure resistance
* Severe bradycardia
* Sinus ostium displacement (acute or chronic)
* Displacement of the auditory canal entrance (acute or chronic)
* Status post-tympanoplasty type I-III \<3 months
* Acute febrile state
* Optic neuritis
* Unstabilized hyperthyroidism

Contra-indication to MRI :

* Non-MRI-compatible pacemaker, cochlear implant, drug-infusion pump or neurostimulator.
* Metallic foreign body in critical area (eye, brain, etc.)
* Ferromagnetic vascular surgical clips of older generation, e.g., for intracranial aneurysm repair.

Where it's running

  • Geneva University Hospitals
    Geneva, Canton of Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.